Wolfgang Miesbach։ Hidden Brain Damage and Progressive Cognitive Decline in iTTP Survivors
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn, about a recent article by Fahad Hannan et al, published in Journal of Thrombosis and Haemostasis:
”Hidden Brain Damage: Advanced Neuroimaging Reveals Progressive Cognitive Decline in iTTP Survivors—Even After Remission.
This Canadian multicenter prospective study (2016-2024) tracked 22 immune-mediated TTP survivors over 12 months using a dual-imaging approach rarely applied in thrombotic microangiopathy research:
Advanced MRI Techniques
Diffusion tensor imaging (DTI) with 64-directional tractography to map white matter integrity across 8 cognitive pathways—assessing fractional anisotropy, radial diffusivity, and microstructural damage
CT-Perfusion Imaging
150-second protocol on 256-slice scanners quantifying cerebral blood flow, cerebral blood volume, and blood-brain barrier permeability through permeability-surface product measurements
Validated Cognitive Testing
Creyos/Cambridge Brain Sciences battery across memory, reasoning, verbal ability, and concentration domains
What They Found:
Despite achieving clinical remission, all patients (100%) exhibited compromised blood-brain barrier integrity at both timepoints. 82% showed structural brain abnormalities at baseline, with progressive deterioration:
- Significant gray and white matter volume loss continued throughout follow-up
- White matter tract damage worsened in pathways critical for memory and verbal processing
- Cognitive impairment persisted significantly below control levels—memory (-0.94 vs -0.25) and verbal domains (-1.05 vs -0.28)
- BBB permeability improved slightly (p=0.04) but remained substantially compromised
The Clinical Challenge:
Brain injury in iTTP extends far beyond the acute phase. Persistent vascular dysfunction drives ongoing neurological decline independent of clinical recovery—yet current care protocols rarely include long-term neurological monitoring.
This research advocates strongly for:
- Standardized longitudinal brain health assessments in iTTP survivors
- Early neuroprotective intervention strategies
- Aggressive relapse prevention
- Reconsideration of treatment accessibility (rituximab, novel agents)
Congratulations to Shih-Han Susan Huang and co authors Journal of Thrombosis and Haemostasis (JTH).”
Title: Endothelial Injury to Cognitive Decline: A 12-month Follow-up Using CT-Perfusion and Diffusion MRI in Immune-mediated Thrombotic Thrombocytopenic Purpura
Authors: Fahad Hannana, Jonathan D. Thiessen, Christopher J. Patriquin, Katerina Pavenski, Leandro Tristao, Ting-Yim Lee, Daniel Mendes, Stefan Poirier, Jean Théberge, Jennifer Mandzia, Melissa Al-Jaishi, Kerri Gallo, Shih-Han Susan Huang
Read the Full Article on Journal of Thrombosis and Haemostasis․
Find more posts featuring Wolfgang Miesbach on Hemostasis Today.
-
Mar 24, 2026, 17:12Ron DePinho: CRISPR Progress in Cellular Immunotherapy
-
Mar 24, 2026, 17:12Martine Gilard։ Women’s Heart Health as a National Priority
-
Mar 24, 2026, 17:11Erik Nelson։ Blood Vessels – The Silent System That Determines How You Age
-
Mar 24, 2026, 17:10Anthony Yazbeck: Why the Hemolysin Test Matters More Than You Think
-
Mar 24, 2026, 17:09Marcos Gamboa Chele: Are We Asking for Too Many Thrombophilia Panels?
-
Mar 24, 2026, 17:06Anita Brikman: PPTA Explores India’s Growing Plasma-Derived Medicines Industry
-
Mar 24, 2026, 17:01Victor Canata: Is Embolectomy the Best Treatment for Pulmonary Thromboembolism?
-
Mar 24, 2026, 16:57Hossam Qassem: The Stepwise Investigation Framework for ICU Hemoglobin Drop
-
Mar 24, 2026, 16:56Alan Nurden: Targeting Splice Site Variants in Alport Syndrome with Antisense Therapy